Target intelligence / Profile preview

Monilinia fructicola (M. fructicola)

Target
M. fructicola
Molecular classification
Fungal Pathogen, Ascomycota, Other
01

Overview

Monilinia fructicola is a filamentous ascomycete fungus and the primary causative agent of brown rot in stone fruits such as peaches, nectarines, cherries, and plums (EPPO Global Database, 2020). As a necrotrophic pathogen, it colonizes host tissues by secreting cell-wall-degrading enzymes and toxic metabolites, leading to blossom blight, twig cankers, and rapid fruit decay (Amiri et al., 2009). Although it is not a target for human therapeutic intervention, it is a major target for agricultural fungicides. These chemical agents typically aim to disrupt vital fungal processes, including the biosynthesis of ergosterol, mitochondrial respiration, and microtubule assembly (Hu et al., 2011). The high economic impact of M. fructicola is exacerbated by its ability to develop resistance to several classes of fungicides, which has prompted extensive research into its genome and the identification of specific molecular targets like sterol 14-alpha-demethylase and succinate dehydrogenase (Luo et al., 2010; Chen et al., 2013).

Other names
Brown rot fungusSclerotinia fructicolaMonilia fructicolaAmerican brown rot of stone fruits
02

Mechanism of action

Fungicides targeting this organism work by inhibiting sterol 14-alpha-demethylase (DMIs), the cytochrome bc1 complex (QoIs), succinate dehydrogenase (SDHIs), or beta-tubulin assembly (benzimidazoles).

03

Biological functions

Fungal pathogenesisNecrotrophic growthHost cell wall degradationErgosterol biosynthesisConidiation and spore germination
04

Disease associations

Brown rot of stone fruitsBlossom blightTwig cankerPostharvest fruit decay
05

Safety considerations

Development of multi-fungicide resistanceEnvironmental persistence and toxicity to non-target aquatic lifeEconomic risk due to total crop failure
06

Interacting drugs

Tebuconazole

6 more in the full profile.

07

Biomarkers

Beta-tubulin E198A/E198K mutations (benzimidazole resistance)Cytochrome b G143A mutation (QoI resistance)CYP51 gene overexpression or mutations (DMI resistance)

Beyond the preview

Go deeper on Monilinia fructicola (M. fructicola).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monilinia fructicola (M. fructicola).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call